Publications

Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case-Control Study.

Prapiadou S, Langefeld CD, Sekar P, et al. Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case-Control Study. Annals of clinical and translational neurology. 2025. doi:10.1002/acn3.70230Google Scholar PubMed DOI

Fan B, Dennis E, Mehta NH, et al. Somatic Mutation Identified in a Patient with Calvarial Venous Malformations. Genes. 2025;16(10). doi:10.3390/genes16101123Google Scholar PubMed DOI

Yoo YC, Lin L, Lee S, Shin YR, Oh JE, Kim NY. Palonosetron, a 5-HT3 Receptor Antagonist, Induces G1 Cell Cycle Arrest and Autophagy in Gastric Cancer Cells. International journal of molecular sciences. 2025;26(20). doi:10.3390/ijms262010039Google Scholar PubMed DOI

Mboowa G. Reimagining Tuberculosis Control in the Era of Genomics: The Case for Global Investment in Genomic Surveillance. Pathogens (Basel, Switzerland). 2025;14(10). doi:10.3390/pathogens14100975Google Scholar PubMed DOI

Martins F, André R, Planet E, et al. The ’mono-side’ of cutaneous adverse drug reactions. Journal of the European Academy of Dermatology and Venereology : JEADV. 2025. doi:10.1111/jdv.70128Google Scholar PubMed DOI

Carver S, Taraszka K, Groha S, Gusev A. Discovery of disease-associated cellular states using ResidPCA in single-cell RNA and ATAC sequencing data. HGG advances. 2025:100538. doi:10.1016/j.xhgg.2025.100538Google Scholar PubMed DOI

Zimerman A, Kamanu FK, Melloni GEM, et al. Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic Disease. European journal of preventive cardiology. 2025. doi:10.1093/eurjpc/zwaf693Google Scholar PubMed DOI

Butt H, Sathish S, London E, et al. Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model. Blood advances. 2025. doi:10.1182/bloodadvances.2025017321Google Scholar PubMed DOI

Tesfai K, Díaz LA, Arab JP, et al. Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Alimentary pharmacology & therapeutics. 2025. doi:10.1111/apt.70433Google Scholar PubMed DOI

Urbut SM, Chen Q, Sui Y, et al. Genetics of Cholesterol and Coronary Disease Risk across Six Global Ancestries. NEJM evidence. 2025;4(11):EVIDoa2500105. doi:10.1056/EVIDoa2500105Google Scholar PubMed DOI